B6.Cg-Pdgfrbtm1.1Rheu/Kctt

Status

Available to order

EMMA IDEM:02257
International strain nameB6.Cg-Pdgfrbtm1.1Rheu/Kctt
Alternative namePdgfrb-D849N
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolPdgfrbtmRheu
Gene/Transgene symbolPdgfrb

Information from provider

ProviderRainer Heuchel
Provider affiliationLudwig Institute for Cancer Research
Genetic informationThe Pdgfrb D849N mutation is an activating mutation conferring low constitutive receptor activity/autophosphorylation. A similar, but stronger, mutation (D842V) has been found in the PDGFRA gene in gastrointestistinal stromal tumors (GISTs) in humans. The targeting vector consisted of a 1.7-kb EcoRV-SpeI genomic 5'-fragment, followed by a PGKneobpA expression cassette flanked by loxP sites, a 5-kb SpeI-XhoI genomic 3'-fragment containing the point mutated exon 18, and a herpes simplex virus thymidine kinase expression cassette in pBluescript SK(+).
Phenotypic informationNo overt phenotype.
Breeding historyBackcrossed to C57BL/6ChR (N9), then cross with cre recombinase deleter strain (N6 in C57BL/6) to remove neo−cassette, then one backcross to C57BL/6.
References
  • A gain of function mutation in the activation loop of platelet-derived growth factor beta-receptor deregulates its kinase activity.;Chiara Federica, Goumans Marie-José, Forsberg Henrik, Ahgrén Aive, Rasola Andrea, Aspenström Pontus, Wernstedt Christer, Hellberg Carina, Heldin Carl-Henrik, Heuchel Rainer, ;2004;The Journal of biological chemistry;279;42516-27; 15284236
  • Platelet-derived growth factor receptor-beta promotes early endothelial cell differentiation.;Rolny Charlotte, Nilsson Ingrid, Magnusson Peetra, Armulik Annika, Jakobsson Lars, Wentzel Parri, Lindblom Per, Norlin Jenny, Betsholtz Christer, Heuchel Rainer, Welsh Michael, Claesson-Welsh Lena, ;2006;Blood;108;1877-86; 16690964

Information from EMMA

Archiving centreKarolinska Institutet, Stockholm, Sweden
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • A gain of function mutation in the activation loop of platelet-derived growth factor beta-receptor deregulates its kinase activity.;Chiara Federica, Goumans Marie-José, Forsberg Henrik, Ahgrén Aive, Rasola Andrea, Aspenström Pontus, Wernstedt Christer, Hellberg Carina, Heldin Carl-Henrik, Heuchel Rainer, ;2004;The Journal of biological chemistry;279;42516-27; 15284236
  • Platelet-derived growth factor receptor-beta promotes early endothelial cell differentiation.;Rolny Charlotte, Nilsson Ingrid, Magnusson Peetra, Armulik Annika, Jakobsson Lars, Wentzel Parri, Lindblom Per, Norlin Jenny, Betsholtz Christer, Heuchel Rainer, Welsh Michael, Claesson-Welsh Lena, ;2006;Blood;108;1877-86; 16690964

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).